TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N, Hawkins C, Bouffet E, Pienkowska M, Lafay-Cousin L, Gozali A, Zhukova N, Shane L, Gonzalez I, Finlay J, Malkin D.
Tabori U, et al. Among authors: shlien a.
J Clin Oncol. 2010 Apr 20;28(12):1995-2001. doi: 10.1200/JCO.2009.26.8169. Epub 2010 Mar 22.
J Clin Oncol. 2010.
PMID: 20308654